Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2019 | Story Nonsindiso Qwabe | Photo Barend Nagel
Victoria Read more
Victoria the mannequin has become a familiar face in Nursing classrooms

She has an uncanny ability to move her eyes towards the sound of voices in a room, her voice shrills and squeals when she's in pain, she throws in a Spanish word or two, and she releases bodily fluids just like a real human would. 

These are just some of the quirky characteristics that make up the new R1,76 million-rand birthing mannequin in the School of Nursing's Simulation Unit, who goes by the name Victoria. She weighs more than 80 kg and is almost 1,7 metres high. With features such as real eyelashes, eyebrows, and hair, you can't help but do a double take when you lay eyes on her. 

Students getting practical experience

While the unit has other mannequins used for training Nursing students in each year or their study, Simulation Coordinator from the School of Nursing in the Faculty of Health Sciences, Cecile Fourie, said Victoria was a major upgrade for the school because of her versatility. Victoria would further enhance the school's quality of teaching by training students in their final year of undergraduate studies as well as those pursuing their postgraduate studies, about the ins and outs of pregnancy and other female morbidities, Fourie said. 

"We try to make our scenarios as real and authentic as possible and we've seen how much our students have grown. Introducing Victoria to our pre- and postgraduate students will prepare them to be competent in clinical practice." 

Meet Victoria

So, what exactly can Victoria do? 

Fourie said while the other mannequins were made with screws that made them look robot-like, Victoria was made with silicone and given a clean finish to make her appear life-like. The other mannequins can only blink, but Victoria's eyes move around, she can speak Spanish and French, and she comes with five tummies for different medical scenarios. She has a normal tummy which acts as a closure, an operable tummy for caesarean delivery, a tummy that allows a breeched baby to be twisted and turned from the outside just before delivery, a contraction tummy used for normal vaginal delivery – which also allows Victoria to push, bleed, urinate, and release mineral oil which acts as amniotic fluid. The fifth tummy is postpartum haemorrhage, a condition that is common among South African mothers after delivery. 

"It’s so good that we get to train our students in such real, lifelike circumstances. Through Victoria we're going to try and do our part in lessening maternal deaths, which are so prominent in our country. She can act out all the abnormalities that take place in a real delivery, and she can also have other medical conditions such as a heart attack," Fourie said.



News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept